While biotech and pharma are referred to as sunrise sectors, a new study reveals only an insignificant amount of innovative, patentable work has been carried out so far as part of the outsourcing process to Indian pharma-biotech firms. The study titled “work outsourced to Indian biotech and pharma companies is not yet significantly innovative,” focuses on projects outsourced and has been published in the latest edition of Current Science.